Table 2.
Correlation matrix for disease activity and impairment.
| Serum CLP | Serum NFL | |
|---|---|---|
| Disease duration | r = 0.09, p = 0.47 | r = 0.32, p = 0.006** |
| Disease activity status | p = 0.025* | p = 0.74 |
| MRC sum score | r = 0.35, p = 0.013* | r = −0.42, p = 0.0008*** |
| INCAT | r = 0.007, p = 0.95 | r = 0.32, p = 0.009** |
| Grip strength | RIGHT ARM: r = 0.06, p = 0.673 LEFT ARM: r = 0.02, p = 0.88 | RIGHT ARM: r = −0.34, p = 0.025*LEFT ARM: r = −0.46, p = 0.002** |
| Walking distance | r = 0.19, p = 0.167 | r = −0.35, p = 0.004** |
Correlation matrices of parameters of clinical disease activity and impairment of serum calprotectin (CLP) and serum neurofilament light chain (sNfl) in CIDP patients and variants. Values are Spearman r;
p < 0.05;
p < 0.01;
p < 0.001 or tested using Kruskal–Wallis test (disease activity status scale). MRC, medical research council sum score; INCAT, inflammatory neuropathy cause and treatment sensory sum score.